Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Gene expression profiling is crucial for understanding cancer development.
• Human prostate tumorigenesis involves complex alterations in gene expression patterns.

Purpose of the Study:

• To apply cDNA microarray technology to profile gene expression changes in human prostate cancer.
• To identify novel genes and pathways involved in prostate tumorigenesis.
• To evaluate data normalization and validation methods for gene expression studies.

Main Methods:

• Utilized cDNA microarray analysis to examine the expression of 588 genes in normal and malignant prostate tissues.
• Employed four data normalization techniques, with ACTB expression normalization proving most reliable.
• Validated array findings using Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Northern blot analyses.

Main Results:

• Identified 15 differentially expressed genes (2.6%) between normal and malignant prostate tissues.
• Eight previously reported genes and seven novel genes (MLH1, CYP1B1, RFC4, EPHB3, MGST1, BTEB2, MLP) were identified.
• These genes are involved in metabolic and signaling pathways potentially disrupted in prostate cancer.
• RT-PCR and Northern blot analyses confirmed expression trends but showed variability in quantifying fold differences.

Conclusions:

• cDNA microarray technology is effective for profiling gene expression in prostate cancer.
• Normalization to ACTB expression is a rigorous method for data analysis.
• Seven novel genes were identified as potentially significant in prostate tumorigenesis.
• Accurate validation of quantitative gene expression differences from array data is essential.